• Publications
  • Influence
Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis.
The American Thoracic Society, Centers for Disease Control and Prevention, and Infectious Diseases Society of America jointly sponsored the development of this guideline for the treatment ofExpand
  • 529
  • 38
  • PDF
Advances in the development of new tuberculosis drugs and treatment regimens
Despite the introduction 40 years ago of the inexpensive and effective four-drug (isoniazid, rifampicin, pyrazinamide and ethambutol) treatment regimen, tuberculosis (TB) continues to causeExpand
  • 659
  • 23
The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis.
Global tuberculosis incidence has declined marginally over the past decade, and tuberculosis remains out of control in several parts of the world including Africa and Asia. Although tuberculosisExpand
  • 321
  • 20
  • PDF
Towards tuberculosis elimination: an action framework for low-incidence countries
This paper describes an action framework for countries with low tuberculosis (TB) incidence (<100 TB cases per million population) that are striving for TB elimination. The framework sets outExpand
  • 511
  • 18
  • PDF
Clinical practice. Latent tuberculosis infection.
A 44-year-old man who recently immigrated from Peru is found to have induration of 16 mm on a tuberculin skin test. He received bacille Calmette–Guerin vaccine as an infant and is asymptomatic. ChestExpand
  • 432
  • 10
Drug-resistant tuberculosis: time for visionary political leadership.
Two decades ago, WHO declared tuberculosis a global emergency, and invested in the highly cost-effective directly observed treatment short-course programme to control the epidemic. At that time, mostExpand
  • 236
  • 8
  • PDF
Treatment outcomes of patients with HIV and tuberculosis.
RATIONALE The optimal length of tuberculosis treatment in patients coinfected with HIV is unknown. OBJECTIVES To evaluate treatment outcomes for HIV-infected patients stratified by duration ofExpand
  • 153
  • 8
Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline
Background: The American Thoracic Society, U.S. Centers for Disease Control and Prevention, European Respiratory Society, and Infectious Diseases Society of America jointly sponsored this newExpand
  • 72
  • 7
  • PDF
Performance of Purified Antigens for Serodiagnosis of Pulmonary Tuberculosis: a Meta-Analysis
ABSTRACT Serological antibody detection tests for tuberculosis may offer the potential to improve diagnosis. Recent meta-analyses have shown that commercially available tests have variable accuraciesExpand
  • 185
  • 6
Executive Summary: Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible
The American Thoracic Society, Centers for Disease Control and Prevention, and Infectious Diseases Society of America jointly sponsored the development of this guideline for the treatment ofExpand
  • 108
  • 6
  • PDF
...
1
2
3
4
5
...